Balancing Clinical Evidence and Commercial Strategy to Build Science-Led Differentiation in an Increasingly Crowded Microbiome Market
2:00 pm - Tuesday 10th November 2026
- Examining the tension between marketing-driven claims and robust clinical evidence to define what kind of science-led company you want to be in the microbiome ecosystem
- Leveraging proprietary R&D and clinical data as long-term competitive differentiators to stand out as the microbiome space becomes increasingly crowded with marketing-focused competitors
- Integrating microbiome products alongside conventional healthcare approaches to transition from natural health consumers toward evidence-based recommendations by mainstream healthcare providers
